Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tranylcypromine 2 pcpa hcl'

Search results for: 'tranylcypromine 2 pcpa hcl'

Items 51-60 of 118

Page
per page
  1. Ki8751
    A1821 Ki8751
    Target: VEGFR
    Summary: VEGFR-2 inhibitor,potent and selective
      ≥23.45 mg/mL
  2. Vatalanib
    A3969 Vatalanib
     1 Citation
    Target: VEGFR
    Summary: VEGFR-1/-2 inhibitor,cell-permeable
      ≥16.85 mg/mL
  3. Motesanib
    A3632 Motesanib
    Target: VEGFR
    Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
      ≥42 mg/mL
  4. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR inhibitor
      ≥21.55 mg/mL
  5. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms tyrosine kinase inhibitor
      ≥48.1 mg/mL
  6. E-3810
    A3378 E-3810
    Summary: VEGF/FGF dual inhibitor, potent and selective
      Soluble in DMSO
  7. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL
  8. Tivozanib (AV-951)
    A2251 Tivozanib (AV-951)
    Target: VEGFR
    Summary: VEGFR inhibitor,potent and selective
      ≥22.75 mg/mL
  9. Sunitinib malate
    A8255 Sunitinib malate
     2 Citation
    Target: VEGFR
    Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
      ≥26.65 mg/mL
  10. LDN193189 Hydrochloride
    A3545 LDN193189 Hydrochloride
     1 Citation
    Summary: ALK inhibitor,potent and selective
      ≥27.6 mg/mL

Items 51-60 of 118

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 4item
  2. Ack1 1 item
  3. Axl 1 item
  4. ALK 4item
  5. Broad Spectrum Protein Kinase Inhibitor 3item
  6. c-FMS 1 item
  7. c-Kit 2item
  8. c-MET 8item
  9. c-RET 3item
  10. CSF-1R 1 item
  11. EGFR 24item
  12. FAK 4item
  13. FGFR 6item
  14. FLT3 4item
  15. HER2 7item
  16. IGF1R 2item
  17. Insulin Receptor 3item
  18. IRAK 1 item
  19. Lck 1 item
  20. LRRK2 4item
  21. PDGFR 9item
  22. PTKs/RTKs 1 item
  23. Pyk2 2item
  24. ROR 1 item
  25. Spleen Tyrosine Kinase (Syk) 2item
  26. Src 5item
  27. Tie-2 2item
  28. Trk 1 item
  29. VEGFR 30item
Specificity
  1. Selective 46item
Reversibility
  1. Reversible 6item
  2. Irreversible 4item
Target
  1. Raf 4item
  2. CSF-1R 1 item
  3. FLT3 4item
  4. Eph Receptors 1 item
  5. VEGFR 24item
  6. PDGFR 7item
  7. c-Kit 5item
  8. RET 2item
  9. Bcr-Abl 2item
  10. FGFR 7item
  11. MET 4item
  12. Src 2item
  13. Trk Receptors 2item
  14. EGFR 11item
  15. FAK 3item
  16. BMP and Other Activin Receptors 1 item
  17. Syk 2item
  18. ErbB 2item
  19. c-MET 2item
  20. PKC 1 item
  21. Pyk2 3item
  22. LRRK2 4item
  23. Insulin and Insulin-like Receptors 1 item
  24. ALK 1 item
  25. PKG 1 item
  26. PKA 1 item
  27. Myosin light chain kinases (MLCKs) 1 item
  28. Tie-2 3item
  29. Flk-1 1 item
  30. KDR 1 item
  31. Fyn kinase 1 item
  32. c-Fms tyrosine kinase 1 item
  33. Lyn kinase 1 item
  34. ErbB-2 1 item
  35. DCLK2 1 item
  36. Flk1 1 item
Reported Experiments
  1. Animal Experiments 58item
  2. Cell Experiments 42item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 12item
  7. Cancer 44item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 7item
  14. Glioblastoma 3item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 2item
  17. Liver Cancer 2item
  18. Lung Cancer 3item
  19. Lung Carcinoma 1 item
  20. Lymphoma 1 item
  21. Melanoma 2item
  22. Multiple Myeloma 3item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 7item
  26. Prostate Cancer 3item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 3item
  29. Thyroid Cancer 3item